University of Pennsylvania Perelman School of Medicine
Institution of higher education.
Based in PA
🤖
AI Overview
With $1.0M in lobbying spend across 21 quarterly filings, University of Pennsylvania Perelman School of Medicine is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2018 to 2023.
$1.0M
Total Spend
6
Years Active
1
Firms Hired
5
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, MED, Health Issues, Veterans
- •Monitor the following:
- •Physician payment issues
- •Sustainable Growth Rate (SGR) Formula
- •Non-profit hospital regulations and oversight
- •Comparative effectiveness research
- •Reimbursement issues
- •Monitor the following:
- •FY2018 Omnibus Appropriations Act
- •Precision Medicine Initiative
- •Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 a
- •Physician payment issues
- •Sustainable Growth Rate (SGR) Formula
- •Non-profit hospital regulations and oversight
- •Comparative effectiveness research
- •Reimbursement issues
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.